Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayMar 12, 2018 5:30 pm

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) Starts Presentation at 30th Annual ROTH Conference

KalVista Pharmaceuticals (NASDAQ: KALV) is a clinical-stage pharmaceutical company that discovers, develops, and commercializes small molecule protease inhibitors to treat diseases with significant unmet need. The company’s proprietary portfolio comprises of novel, small molecule plasma kallikrein inhibitors primarily targeting hereditary angioedema (“HAE”) and diabetic macular edema (“DME”). KalVista’s most advanced program, KVD001, has successfully completed its first-in-human study in patients with DME and commenced a phase 2 clinical trial in 2017. For more information, visit the company’s website at www.kalvista.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of…

Continue Reading

MondayMar 12, 2018 5:30 pm

Celsius Holdings, Inc. (NASDAQ: CELH) Starts Presentation at 30th Annual ROTH Conference

Celsius Holdings (NASDAQ: CELH) is a global company with a proprietary, clinically proven formula for its brand CELSIUS®. Celsius Holdings, Inc. has a corporate mission to become the global leader of a branded portfolio which is proprietary, clinically proven or innovative in its category, and offers significant health benefits. CELSIUS®’ original line comes in seven flavors and is also available in single serve powdered packets. CELSIUS®’ new natural line is available in six flavors that are naturally caffeinated and naturally sweetened. For more information, visit the company’s website at www.celsiusholdingsinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content…

Continue Reading

MondayMar 12, 2018 5:24 pm

Groestlcoin ($GRS): A Multi-Purpose, Private Cryptocurrency with Sub-Atomic Fees

In the world of cryptocurrencies where projects are born and fade out repeatedly, Groestlcoin is a project that evidences simplicity, durability, and staying power. Launched in March of 2014, Groestlcoin (Crypto: GRS) started with the goal of being instant, private, and with very low fees. Steady Development The design team for Groestlcoin began with a goal toward adopting the latest advancements to create a basic, multi-purpose cryptocurrency that performs reliably quickly and cheaply. The android app for Groestlcoin was released in December of 2014 and in March of 2015 an Electrum wallet came available. In August of 2015, the Groestlcoin…

Continue Reading

MondayMar 12, 2018 5:00 pm

ShotSpotter, Inc. (NASDAQ: SSTI) Starts Presentation at 30th Annual ROTH Conference

ShotSpotter (NASDAQ: SSTI) is a provider of gunshot detection solutions that aid law enforcement and security personnel in identifying, locating and deterring gun violence. The company provides the most trusted, scalable and reliable gunfire alert and analysis available in the marketplace, with solutions offered on a SaaS-based subscription model. ShotSpotter has deep domain experience and cumulative agency best practice experience that enable the company to deliver measurable outcomes to help mitigate gun violence. The company has multiple patents that have resulted from almost 20 years of innovation in the area of acoustic location technology. For more information, visit the company’s…

Continue Reading

MondayMar 12, 2018 5:00 pm

Galectin Therapeutics, Inc. (NASDAQ: GALT) Starts Presentation at 30th Annual ROTH Conference

Galectin Therapeutics (NASDAQ: GALT) is a biotechnology company focused on the discovery and development and new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. The company is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. Drug candidates based on the company’s unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics’ lead development program is in non-alcoholic steatohepatitis (“NASH”) with cirrhosis, the most advanced form of NASH related fibrosis. Further…

Continue Reading

MondayMar 12, 2018 5:00 pm

Q BioMed, Inc. (QBIO) Starts Presentation at 30th Annual ROTH Conference

Q BioMed (OTCQB: QBIO) is a biomedical acceleration and development company engaged in licensing and acquiring biomedical assets across the healthcare spectrum. The company’s focus is on offering these target assets the strategic resources, developmental support and expansion capital they require to ensure they are able to fulfill their potential for development. This enables these target assets to provide products to the patients that need them. For more information, visit the company’s website at www.QBioMed.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all…

Continue Reading

MondayMar 12, 2018 5:00 pm

Farmer Brothers Co. (NASDAQ: FARM) Starts Presentation at 30th Annual ROTH Conference

Farmer Bros. (NASDAQ: FARM) is a national coffee roaster, wholesaler and distributor of coffee, tea and culinary products. The company’s product lines include organic, direct trade and sustainably-produced coffee. With a robust line of coffee, hot and iced teas, cappuccino mixes, spices, and baking/biscuit mixes, the company delivers extensive beverage planning services and culinary products to its U.S.-based customers. The company serves a wide variety of customers, from small independent restaurants and foodservice operators to large institutional buyers like restaurant and convenience store chains, hotels, casinos, hospitals and gourmet coffee houses, as well as grocery chains with private brand coffee…

Continue Reading

MondayMar 12, 2018 5:00 pm

Cypress Semiconductor Corp. (NYSE: CY) Starts Presentation at 30th Annual ROTH Conference

Cypress Semiconductor (NYSE: CY) is an international provider of advanced embedded system solutions for innovative automotive, industrial, smart home appliances, consumer electronics and medical products. The company’s microcontrollers, analog ICs, wireless and USB-based connectivity solutions and reliable, high-performance memories help engineers design differentiated products and bring them to market quickly. Cypress is committed to providing customers with the quality support and development resources which enables them to disrupt markets by creating new product categories in record time. For more information, visit the company’s website at www.cypress.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides…

Continue Reading

MondayMar 12, 2018 5:00 pm

Daré Bioscience, Inc. (NASDAQ: DARE) Starts Presentation at 30th Annual ROTH Conference

Daré Bioscience (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. Daré currently has two product candidates in clinical development. The first is Ovaprene™, a non-hormonal monthly contraceptive ring intended to provide protection over multiple weeks between menses. The second is SST-6007 a potential treatment for Female Sexual Arousal Disorder. SST-6007 incorporates sildenafil, the same active ingredient in Viagra®, in a proprietary cream formulation that is specifically designed to locally increase blood flow to the vulvar-vaginal tissue in women, leading to a potential improvement in genital arousal response and overall sexual…

Continue Reading

MondayMar 12, 2018 5:00 pm

Blue Bird Corp. (NASDAQ: BLBD) Starts Presentation at 30th Annual ROTH Conference

Blue Bird (NASDAQ: BLBD) is an independent designer and manufacturer of school buses, with more than 550,000 buses sold since its formation in 1927 and approximately 180,000 buses in operation today. Blue Bird focuses on the design, engineering, manufacture and sale of school buses and related parts. The company is the only manufacturer of chassis and body production specifically designed for school bus applications, and offers alternative fuel applications with its propane-powered and compressed natural gas-powered school buses. Blue Bird manufactures school buses at two facilities in Fort Valley, Georgia. Its Micro Bird joint venture operates a manufacturing facility in…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000